有機医薬品添加剤市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、機能別、用途別、地域別、競合別、2020～2030年

有機医薬品添加剤の世界市場規模は2024年に103億5,000万米ドルとなり、予測期間には165億米ドルに達すると予測され、2030年までのCAGRは8.06%です。

有機医薬品添加剤の世界市場は、製薬業界の中でもダイナミックで急速に発展している分野であり、今後数年間で大幅な成長が見込まれています。医薬品賦形剤は、医薬品の安定性、バイオアベイラビリティ、総合的な性能を高めるために製剤に添加される不活性物質です。天然由来の有機医薬品添加剤は、オーガニック医薬品やクリーンラベル医薬品への需要の高まりにより、大きな注目を集めています。

この市場成長の主な促進要因のひとつは、医薬品における有機・天然成分に対する消費者の意識と嗜好の高まりです。個人の健康意識が高まり、合成添加物の潜在的な副作用を懸念するようになるにつれ、有機賦形剤へのシフトが顕著になっています。この動向は、クリーンで持続可能なヘルスケアソリューションに向けた広範な動きと一致し、有機医薬品添加剤の需要を牽引しています。

さらに、世界中の規制機関がより安全で環境に優しい賦形剤の使用を提唱しており、有機代替品市場をさらに後押ししています。これらの賦形剤は、セルロース、デンプン、ガムなどの植物由来の材料から供給されることが多く、医薬品製剤に持続可能で環境に優しい選択肢を提供しています。

さらに、製薬業界の継続的な研究開発努力は、バイオテクノロジーやナノテクノロジーの進歩と相まって、革新的な有機賦形剤処方の機会を生み出しています。これらの技術革新は、ドラッグデリバリー、溶解性、バイオアベイラビリティにおける特定の課題に対処することを目的としており、有機賦形剤が新規薬剤製剤の開発において重要な役割を果たすための扉を開くものです。

主な市場促進要因

有機製品に対する消費者の嗜好の高まり

主な市場課題

有機原料の入手可能性の制限とばらつき

主要市場動向

クリーンラベル医薬品に対する消費者需要の高まり

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の有機医薬品添加剤市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（油脂化学品、炭水化物、石油化学品、タンパク質、その他）
  • 機能別（バインダー、コーティング剤、着色剤、崩壊剤、その他の機能）
  • 用途別（経口製剤、局所製剤、非経口製剤、その他の用途）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • タイプ別
  • 機能別
  • 用途別
  • 地域別

第5章 アジア太平洋地域の有機医薬品添加剤市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 機能別
  • 用途別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の有機医薬品添加剤市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の有機医薬品添加剤市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の有機医薬品添加剤市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの有機医薬品添加剤市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界の有機医薬品添加剤市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Roquette Freres SA
• DuPont de Nemours Inc.
• Ashland Inc.
• BASF SE
• Kerry Group plc
• Evonik Industries AG
• Croda International plc
• The Lubrizol Corporation
• Innophos Holdings Inc.
• Wacker Chemie AG

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Organic Pharmaceutical Excipients Market was valued at USD 10.35 Billion in 2024 and is expected to reach USD 16.50 Billion in the forecast period with a CAGR of 8.06% through 2030. The Global Organic Pharmaceutical Excipients Market is a dynamic and rapidly evolving sector within the pharmaceutical industry, poised for substantial growth in the coming years. Pharmaceutical excipients are inactive substances that are added to drug formulations to enhance their stability, bioavailability, and overall performance. Organic pharmaceutical excipients, derived from natural sources, have gained significant attention due to the increasing demand for organic and clean-label pharmaceutical products.

One of the key drivers of this market's growth is the rising consumer awareness and preference for organic and natural ingredients in pharmaceuticals. As individuals become more health-conscious and concerned about the potential side effects of synthetic additives, there has been a notable shift towards organic excipients. This trend aligns with the broader movement towards clean and sustainable healthcare solutions, driving the demand for organic pharmaceutical excipients.

Additionally, regulatory bodies across the globe have been advocating for the use of safer and more environmentally friendly excipients, further propelling the market for organic alternatives. These excipients, often sourced from plant-based materials such as cellulose, starch, and gums, offer a sustainable and eco-friendly option for pharmaceutical formulation.

Furthermore, the pharmaceutical industry's ongoing research and development efforts, coupled with advancements in biotechnology and nanotechnology, have created opportunities for innovative organic excipient formulations. These innovations aim to address specific challenges in drug delivery, solubility, and bioavailability, opening doors for organic excipients to play a crucial role in the development of novel drug formulations.

Key Market Drivers

Increasing Consumer Preference for Organic Products

The increasing consumer preference for organic products is a significant driving force behind the growing global organic pharmaceutical excipients market. In recent years, there has been a discernible shift in consumer attitudes towards health and wellness, leading to a heightened demand for organic and natural alternatives in various aspects of life, including pharmaceuticals.

Consumers today are more health-conscious and discerning than ever before. They are increasingly concerned about the potential side effects and health risks associated with synthetic ingredients and additives in pharmaceutical products. This heightened awareness has led to a growing preference for clean-label medications formulated with organic pharmaceutical excipients. These organic excipients, often sourced from natural materials like cellulose, starch, and gums, are considered safer and more aligned with the principles of holistic health and well-being.

The desire for transparency and clean ingredients in pharmaceuticals has become a central factor in consumer choices. Organic excipients offer the assurance of a natural and sustainable approach to medication, which resonates with consumers seeking healthier alternatives. Furthermore, organic pharmaceutical excipients are generally free from allergens and contaminants, which makes them a safer choice for individuals with sensitivities or allergies. Regulatory bodies have also recognized the importance of organic excipients in pharmaceutical formulations, aligning their guidelines and recommendations with consumer preferences. This convergence of consumer demand and regulatory support has created a conducive environment for the growth of the global organic pharmaceutical excipients market..

In response to the increasing prevalence of GERD, the Global Organic Pharmaceutical Excipients Market has expanded to provide innovative and advanced diagnostic tools. These tools include pH monitoring systems, impedance-pH monitoring systems, and other cutting-edge devices designed to precisely assess and diagnose GERD. Additionally, the market has seen the development of patient-friendly, minimally invasive testing options, which encourage individuals to seek diagnosis and treatment.

Key Market Challenges

Limited Availability and Variability of Organic Raw Materials

The global organic pharmaceutical excipients market is experiencing robust growth, driven by the rising demand for natural and sustainable pharmaceutical products. Organic excipients, sourced from natural materials like plants and starches, are gaining popularity for their clean-label appeal and eco-friendly attributes. However, one of the key challenges hindering the growth of this market is the limited availability and variability of organic raw materials.

Organic excipients are primarily derived from natural sources, and their quality and availability are influenced by various factors, including climate, soil conditions, and agricultural practices. Unlike synthetic excipients, which can be manufactured with a high degree of precision and consistency, organic raw materials are subject to the vagaries of nature. This inherent variability can pose several challenges for the pharmaceutical industry.

The limited availability of organic raw materials can lead to supply chain disruptions. The production of organic excipients relies on a steady and sustainable supply of organic feedstock. When these raw materials are in short supply due to factors such as adverse weather conditions or fluctuations in crop yields, pharmaceutical manufacturers may face delays in production or increased costs as they seek alternative sources.

the variability in the quality and composition of organic raw materials can impact the consistency of organic excipients. Pharmaceutical formulations require precise and predictable properties to ensure the safety and efficacy of medications. Variability in excipient characteristics can make it challenging to achieve the desired drug formulation attributes, leading to concerns about product performance and patient safety.

Moreover, the variability of organic raw materials can also affect the cost of production. Pharmaceutical companies may need to invest in rigorous quality control processes to mitigate the impact of variations in organic excipients. This additional quality control can lead to increased production costs, potentially making organic excipients less competitive compared to their synthetic counterparts.

Key Market Trends

Rising Consumer Demand for Clean-Label Pharmaceuticals

The rising consumer demand for clean-label pharmaceuticals is a pivotal driver behind the burgeoning global organic pharmaceutical excipients market. In recent years, consumers have become increasingly health-conscious and discerning about the products they consume, including medications. This shift in consumer preferences towards clean-label pharmaceuticals, which are characterized by transparent ingredient lists containing natural and organic components, has created a substantial surge in demand for organic excipients.

Consumers are now more than ever concerned about the safety and efficacy of the medications they take, as well as the potential side effects of synthetic additives and artificial ingredients. They are actively seeking pharmaceutical products that align with their preference for natural and sustainable ingredients, and organic excipients fit the bill perfectly.

Organic excipients, sourced from natural materials like plant-based cellulose, starch, and gums, offer consumers a sense of transparency and assurance in their pharmaceuticals. These excipients are perceived as safer, cleaner, and more environmentally friendly than their synthetic counterparts. They resonate with consumers' desires for holistic health and well-being and cater to their demand for clean-label products free from synthetic and artificial additives.

The clean-label movement extends beyond the food and beverage industry, where it originated, and has made its way into pharmaceuticals. Consumers now prioritize pharmaceutical products that contain recognizable and natural ingredients, which has placed organic excipients in the spotlight.

Additionally, regulatory bodies have taken note of this consumer trend, encouraging pharmaceutical manufacturers to opt for safer and more environmentally friendly excipients in their formulations. The regulatory support for clean-label pharmaceuticals, which often includes organic excipients, further propels their market growth.

Key Market Players

• Roquette Freres SA
• DuPont de Nemours Inc.
• Ashland Inc.
• BASF SE
• Kerry Group plc
• Evonik Industries AG
• Croda International plc
• The Lubrizol Corporation
• Innophos Holdings Inc.
• Wacker Chemie AG

Report Scope:

In this report, the Global Organic Pharmaceutical Excipients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organic Pharmaceutical Excipients Market, By Type:

• Oleochemicals
• Carbohydrates
• Petrochemicals
• Protein
• Other

Organic Pharmaceutical Excipients Market, By Function:

• Binders
• Coating Agents
• Colorants
• Disintegrates
• Other Functions

Organic Pharmaceutical Excipients Market, By Application:

• Oral Formulations
• Topical Formulations
• Parenteral Formulations
• Other Applications

Organic Pharmaceutical Excipients Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Organic Pharmaceutical Excipients Market.

Available Customizations:

Global Organic Pharmaceutical Excipients Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Organic Pharmaceutical Excipients Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Type (Oleochemicals, Carbohydrates, Petrochemicals; Protein, Other)
  • 4.2.2. By Function (Binders, Coating Agents, Colorants, Disintegrates, Other Functions)
  • 4.2.3. By Application (Oral Formulations, Topical Formulations, Parenteral Formulations, Other Applications)
  • 4.2.4. By Region
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Type
  • 4.3.2. By Function
  • 4.3.3. By Application
  • 4.3.4. By Region

5. Asia Pacific Organic Pharmaceutical Excipients Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By Function
  • 5.2.3. By Application
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Organic Pharmaceutical Excipients Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Type
      • 5.3.1.2.2. By Function
      • 5.3.1.2.3. By Application
  • 5.3.2. India Organic Pharmaceutical Excipients Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Type
      • 5.3.2.2.2. By Function
      • 5.3.2.2.3. By Application
  • 5.3.3. Australia Organic Pharmaceutical Excipients Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Type
      • 5.3.3.2.2. By Function
      • 5.3.3.2.3. By Application
  • 5.3.4. Japan Organic Pharmaceutical Excipients Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Type
      • 5.3.4.2.2. By Function
      • 5.3.4.2.3. By Application
  • 5.3.5. South Korea Organic Pharmaceutical Excipients Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Type
      • 5.3.5.2.2. By Function
      • 5.3.5.2.3. By Application

6. Europe Organic Pharmaceutical Excipients Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Function
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Organic Pharmaceutical Excipients Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Function
      • 6.3.1.2.3. By Application
  • 6.3.2. Germany Organic Pharmaceutical Excipients Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Function
      • 6.3.2.2.3. By Application
  • 6.3.3. Spain Organic Pharmaceutical Excipients Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Function
      • 6.3.3.2.3. By Application
  • 6.3.4. Italy Organic Pharmaceutical Excipients Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By Function
      • 6.3.4.2.3. By Application
  • 6.3.5. United Kingdom Organic Pharmaceutical Excipients Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By Function
      • 6.3.5.2.3. By Application

7. North America Organic Pharmaceutical Excipients Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Function
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Organic Pharmaceutical Excipients Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Function
      • 7.3.1.2.3. By Application
  • 7.3.2. Mexico Organic Pharmaceutical Excipients Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Function
      • 7.3.2.2.3. By Application
  • 7.3.3. Canada Organic Pharmaceutical Excipients Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Function
      • 7.3.3.2.3. By Application

8. South America Organic Pharmaceutical Excipients Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Function
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Organic Pharmaceutical Excipients Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Function
      • 8.3.1.2.3. By Application
  • 8.3.2. Argentina Organic Pharmaceutical Excipients Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Function
      • 8.3.2.2.3. By Application
  • 8.3.3. Colombia Organic Pharmaceutical Excipients Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Function
      • 8.3.3.2.3. By Application

9. Middle East and Africa Organic Pharmaceutical Excipients Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Function
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Organic Pharmaceutical Excipients Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Function
      • 9.3.1.2.3. By Application
  • 9.3.2. Saudi Arabia Organic Pharmaceutical Excipients Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Function
      • 9.3.2.2.3. By Application
  • 9.3.3. UAE Organic Pharmaceutical Excipients Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Function
      • 9.3.3.2.3. By Application

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Organic Pharmaceutical Excipients Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Roquette Freres SA
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. DuPont de Nemours Inc.
• 14.3. Ashland Inc.
• 14.4. BASF SE
• 14.5. Kerry Group plc
• 14.6. Evonik Industries AG
• 14.7. Croda International plc
• 14.8. The Lubrizol Corporation
• 14.9. Innophos Holdings Inc.
• 14.10. Wacker Chemie AG

15. Strategic Recommendations

16. About Us & Disclaimer